Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

COVID-19

  • Home
  • COVID-19
  • Page 2
FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults
Posted inPublic Health Specialties

FDA Approves Updated COVID-19 Vaccines Targeting Latest LP.8.1 Variant for High-Risk and Older Adults

Posted by MedXY By MedXY 08/31/2025
The FDA has authorized updated COVID-19 vaccines from Pfizer and Moderna designed to target the LP.8.1 sublineage, expanding vaccination to adults over 65 and individuals with high-risk conditions, enhancing immune defense against evolving variants.
Read More
Depression and Anxiety Rates Increased Among Racial Groups During the Pandemic
Posted inPsychiatry Public Health Specialties

Depression and Anxiety Rates Increased Among Racial Groups During the Pandemic

Posted by MedXY By MedXY 08/21/2025
A survey reveals significant increases in depression and anxiety rates among various racial groups during the COVID-19 pandemic, highlighting ongoing racial health disparities.
Read More
Kidney-transplant recipients benefit from COVID-19 vaccination
Posted inInfectious Diseases Nephrology news Respiratory Specialties

Kidney-transplant recipients benefit from COVID-19 vaccination

Posted by MedXY By MedXY 08/20/2025
Kidney-transplant recipients on long-term kidney replacement therapy demonstrate significant reductions in COVID-19-related hospitalizations and mortality following three or more vaccine doses, supporting booster vaccinations in this vulnerable population.
Read More
Common Cold and Reduced COVID-19 Risk: Insights from the HEROS Cohort Study on Rhinovirus-Induced Airway Antiviral Responses
Posted inInfectious Diseases Medical News news Respiratory Specialties

Common Cold and Reduced COVID-19 Risk: Insights from the HEROS Cohort Study on Rhinovirus-Induced Airway Antiviral Responses

Posted by MedXY By MedXY 08/20/2025
Recent rhinovirus infection may nearly halve COVID-19 risk and reduce viral load by triggering airway antiviral gene expression, partially explaining children's milder COVID-19 outcomes.
Read More
Symptomatic Respiratory Disease and COVID-19 Testing Among Healthcare Workers: Insights from the Post-Pandemic Era in Ireland
Posted inClinical Updates Infectious Diseases news Public Health Specialties

Symptomatic Respiratory Disease and COVID-19 Testing Among Healthcare Workers: Insights from the Post-Pandemic Era in Ireland

Posted by MedXY By MedXY 08/20/2025
A recent Irish study reveals that 6 in 10 healthcare workers with respiratory symptoms test for COVID-19, while vaccination coverage remains low, highlighting ongoing risks and the need for enhanced infection control and vaccination strategies.
Read More
COVID reinfection may raise risk of persistent symptoms by 35%
Posted inClinical Updates Infectious Diseases news Respiratory Specialties

COVID reinfection may raise risk of persistent symptoms by 35%

Posted by MedXY By MedXY 08/20/2025
Observational data from the RECOVER Initiative suggest that SARS-CoV-2 reinfection raises the risk of long COVID by 35% relative to single infections, with more recent vaccination potentially mitigating this risk.
Read More
Sex-Specific Impact of COVID-19 on Vascular Aging: Evidence from the CARTESIAN Study
Posted inCardiology Infectious Diseases news Specialties

Sex-Specific Impact of COVID-19 on Vascular Aging: Evidence from the CARTESIAN Study

Posted by MedXY By MedXY 08/20/2025
COVID-19 accelerates vascular aging by approximately 5 years, disproportionately affecting women, with vaccination conferring protection primarily in females, highlighting sex-specific immunological responses and long-term vascular risks.
Read More
Razor Blade COVID-19 Variant Drives Up Cases in the U.S.
Posted inInfectious Diseases news Respiratory Specialties

Razor Blade COVID-19 Variant Drives Up Cases in the U.S.

Posted by MedXY By MedXY 08/20/2025
The Stratus variant, known as XFG, now dominates COVID-19 cases in the U.S., complicating recovery efforts amidst rising infections and changing vaccine guidance.
Read More
CDC Retracts Universal COVID-19 Vaccination Recommendation for Pregnancy: Clinical Context, Evidence, and Implications
Posted inMedical News news Public Health Specialties

CDC Retracts Universal COVID-19 Vaccination Recommendation for Pregnancy: Clinical Context, Evidence, and Implications

Posted by MedXY By MedXY 07/30/2025
The CDC no longer universally recommends COVID-19 vaccination during pregnancy, prompting debate among clinicians as the FDA shifts vaccine composition to target the JN.1 variant. This article analyzes the evidence, rationale, and clinical implications.
Read More

Posts pagination

Previous page 1 2
  • Interleukin-6 as a Central Mediator of Therapeutic Success in Acute Lung Injury and COVID-19
  • Bridging the Gap: Understanding and Reducing Diagnostic Delays in Childhood Onset Uveitis
  • Global Axial Length Centile Charts: A New Reference for Myopia Management in Children and Adolescents
  • Systemic Interleukin-6 Inhibition as a Novel Approach to Reduce Diabetic Retinopathy Risk and Progression
  • Patient Characteristics Influencing Treatment Choices in Bilateral Vocal Fold Atrophy: Insights from a Decade of Clinical Data
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prostate cancer public health quality of life randomized clinical trial randomized controlled trial randomized trial risk stratification SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in